| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/13/1997 | EP0788366A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression |
| 08/13/1997 | EP0788364A1 Treatment of urogenital cancer with boron neutron capture therapy |
| 08/13/1997 | EP0788360A1 Boronic ester and acid compounds, synthesis and uses |
| 08/13/1997 | EP0788305A1 Composition for inactivating irritants in fluids |
| 08/13/1997 | CN1156994A New thiazolo £3,2-a| quinoline and thiazolo £3,2-a| naphthyridine derivatives |
| 08/13/1997 | CN1156966A Polynucleotide vaccine for papillomavirus |
| 08/13/1997 | CN1156958A Use of glyceryl triacetate for treating onychomycoses |
| 08/13/1997 | CN1156624A Medicinal preparation with extractive from yangtao root and preparing process thereof |
| 08/13/1997 | CN1156597A Huanghuafuyanling (oral) capsule containing goldenrod for treating gynaecology inflammation and preparing process thereof |
| 08/13/1997 | CN1156589A Application of rifampicin in Linxiao'an medicine for treating gonorrhea |
| 08/13/1997 | CA2197265A1 Target cell-specific vectors for inserting genes into cells, pharmaceuticals comprising such vectors and their use |
| 08/12/1997 | US5656736 Antibacterial, antitumor agents |
| 08/12/1997 | US5656623 Bactericides; antibiotics |
| 08/12/1997 | US5656615 Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals |
| 08/12/1997 | US5656611 Modified polynucleotide and copolymer having polyether segments and polycation segments; stabilizing polynucleic acids and increasing ability to cross cell membranes |
| 08/12/1997 | US5656607 Erythromycin derivatives |
| 08/12/1997 | US5656599 Administering e2 trans-activation repressor fusion protein to treat papilloma virus infection |
| 08/12/1997 | US5656480 Compounds which inhibit HIV replication |
| 08/12/1997 | US5656436 Analog of Haemophilus Hin47 with reduced protease activity |
| 08/12/1997 | US5656275 Recombinant raccoon pox virus comprising the DNA encoding the nucleocapsid protein of feline infectious peritonitis virus |
| 08/12/1997 | US5655652 Center dispense suture package |
| 08/12/1997 | US5655521 Facilitating oxygen delivery through lung by administering fluorocarbon liquid having positive equilibrium coefficient of spreading, introducing breathing gas which mixes with and oxygenates fluorocarbon within lung |
| 08/12/1997 | CA2090562C Chitin-binding protein cb1, method of producing the same and use of the same |
| 08/12/1997 | CA1339263C Fusion proteins and particles |
| 08/12/1997 | CA1339257C Nail lacquer with antimycotic activity, and a process for the preparat ion thereof |
| 08/12/1997 | CA1339256C Treatment of diseases associated with hiv-infections |
| 08/08/1997 | CA2196505A1 Use of phbm for the treatment of infections caused by intracellularly proliferating agents |
| 08/07/1997 | WO1997028273A1 Expression of group b neisseria meningitidis outer membrane (mb3) protein from yeast and vaccines |
| 08/07/1997 | WO1997028269A1 Transduced human hematopoietic stem cells |
| 08/07/1997 | WO1997028263A1 Recombinant expression of s-layer proteins |
| 08/07/1997 | WO1997028178A1 High affinity nucleic acid ligands of complement system proteins |
| 08/07/1997 | WO1997028169A1 Triazole derivatives useful in therapy |
| 08/07/1997 | WO1997028128A1 Heterocyclic compounds useful as pharmaceutical agents |
| 08/07/1997 | WO1997028123A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 08/07/1997 | WO1997027866A1 Methods for retreatment of patients afflicted with hepatitis c using consensus interferon |
| 08/07/1997 | WO1997021815A3 Antifungal proteins |
| 08/07/1997 | WO1997017085A3 A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| 08/07/1997 | DE19603649A1 Rekombinante Expression von S-Layer-Proteinen Recombinant expression of S-layer proteins |
| 08/07/1997 | CA2630098A1 High affinity nucleic acid ligands of complement system proteins |
| 08/06/1997 | EP0787799A1 Staphylococcus aureus WCUH29 SpoIIIE Protein |
| 08/06/1997 | EP0787796A1 Protective epitopes from adenylate cyclase-hemolysin(AC-Hly) and their use for treatment or prevention of Bordetella infections |
| 08/06/1997 | EP0787191A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 08/06/1997 | EP0787190A2 Hepatitis e virus antigens and uses therefor |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787144A1 Major outer membrane protein cd of moraxella |
| 08/06/1997 | EP0787143A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 08/06/1997 | EP0787139A1 Synthetic peptides and vaccines comprising same |
| 08/06/1997 | EP0787138A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 08/06/1997 | EP0787135A1 Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer |
| 08/06/1997 | EP0787132A1 Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
| 08/06/1997 | EP0787126A1 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents |
| 08/06/1997 | EP0787121A1 Legionella specific antibiotic, a microorganism producing the antibiotic and a process for producing the same |
| 08/06/1997 | EP0787012A1 Suppression of proteolytic activity by dysfunctional protease formation |
| 08/06/1997 | EP0787011A1 Pharmaceutical compositions |
| 08/06/1997 | EP0786999A1 Combination method for acne treatment |
| 08/06/1997 | EP0615458B1 Method of reducing medical device related infections |
| 08/06/1997 | CN1156456A 4-£2-amino-6-(cyclopropylamino)-9H-purin-9-yl|-2-cyclopentene-1-methanol succinate as antiviral agent |
| 08/06/1997 | CN1156449A Dihygropyridine derivatives as bradykinin antagonists |
| 08/06/1997 | CN1156404A Antibacterial oil-in-water emulsions |
| 08/06/1997 | CN1156023A Triazazole nucleoside aerosol and its preparing method |
| 08/06/1997 | CN1035555C Process for diastereoselective synthesis of nucleosides |
| 08/06/1997 | CN1035554C Beta-lactam analogs and its preparing process |
| 08/06/1997 | CA2196909A1 Derivatives of 3-bromo- and 3, 3-dibromo-4-oxo-1-azetidines, processes for the preparation thereof and their use |
| 08/06/1997 | CA2196862A1 Substituted oxazolidinones |
| 08/06/1997 | CA2196859A1 Heteroaryl-oxazolidinones |
| 08/05/1997 | US5654435 Substituted arylphenyloxazolindinones |
| 08/05/1997 | US5654432 Process of preparing michellamine compounds |
| 08/05/1997 | US5654428 Substituted heteroarylphenyloxazolidinones |
| 08/05/1997 | US5654415 Antisense oligonucleotides to p53 |
| 08/05/1997 | US5654411 Reacting a prokinetic 4?-thiocarbonylimidazolylerythromycin with tris/trimethylsilyl/silane to remove the 4?-substituent to form the 4?-deoxyerythrmycin |
| 08/05/1997 | US5654318 Bicyclic amine derivatives |
| 08/05/1997 | US5654271 Fungicidally active compounds |
| 08/05/1997 | US5654195 Vectors expressing hybrid viruses, methods of use and novel assays |
| 08/05/1997 | US5654136 Polypeptide |
| 08/05/1997 | US5653976 Recombinant varicella-zoster virus and process for constructing same |
| 08/05/1997 | CA1339240C Synthetic vaccine against aids virus |
| 08/05/1997 | CA1339220C Fatty acid analog enzyme substrates |
| 08/05/1997 | CA1339216C Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent |
| 08/05/1997 | CA1339215C Rifapentine hydrohalides |
| 08/05/1997 | CA1339205C Oligonucleotide-polyamide conjugates |
| 08/05/1997 | CA1339193C Human rhinovirus receptor protein that inhibits virus infectivity |
| 07/31/1997 | WO1997027311A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 07/31/1997 | WO1997027301A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | WO1997027288A1 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997027206A1 Oligonucleotide analogs |
| 07/31/1997 | WO1997027205A1 Imidazo[1,2-a]pyridine c-nucleosides as antiviral agents |
| 07/31/1997 | WO1997027204A1 Modified benzimidazole nucleosides as antiviral agents |
| 07/31/1997 | WO1997027201A1 Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine |
| 07/31/1997 | WO1997027188A1 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents |
| 07/31/1997 | WO1997027180A1 Aspartyl protease inhibitors |
| 07/31/1997 | WO1997027049A1 Hyperpolarizable compounds and devices fabricated therefrom |
| 07/31/1997 | WO1997026914A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | WO1997026908A1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 07/31/1997 | WO1997026906A1 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components |
| 07/31/1997 | WO1997026891A1 Sphingolipids effective against bacteria, parasites, protozoans, fungi and viruses |
| 07/31/1997 | WO1997026886A1 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria |
| 07/31/1997 | WO1997026882A1 Nucleoside analogs in combination therapy of herpes simplex infections |
| 07/31/1997 | WO1997026880A2 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
| 07/31/1997 | WO1997026867A2 Solid instant-release forms of administration and process for producing the same |